Taconic Capital Advisors’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMGN
Taconic Capital Advisors's IMGN Position: Q1 2024 in Review
Taconic Capital Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,325,000 shares — an estimated $39.3M sold.
Taconic Capital Advisors first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $39.3M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Taconic Capital Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Taconic Capital Advisors sold 1,325,000 Immunogen Inc shares in Q1 2024, an estimated $39.3M.
- Taconic Capital Advisors first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
- Taconic Capital Advisors's Immunogen Inc position peaked at $39.3M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Taconic Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.